Xavier Altafaj

2.0k total citations
43 papers, 1.4k citations indexed

About

Xavier Altafaj is a scholar working on Molecular Biology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Xavier Altafaj has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 22 papers in Genetics and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Xavier Altafaj's work include Genetics and Neurodevelopmental Disorders (18 papers), Down syndrome and intellectual disability research (14 papers) and Ion channel regulation and function (9 papers). Xavier Altafaj is often cited by papers focused on Genetics and Neurodevelopmental Disorders (18 papers), Down syndrome and intellectual disability research (14 papers) and Ion channel regulation and function (9 papers). Xavier Altafaj collaborates with scholars based in Spain, France and United States. Xavier Altafaj's co-authors include Mara Dierssen, Michel Ronjat, Xavier Estivill, Cristina Fillat, Susana de la Luna, Mónica Álvarez‐Fernández, Michel De Waard, Carlos Sindreu, Roberto Coronado and Eulàlia Martı́ and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Chemistry.

In The Last Decade

Xavier Altafaj

43 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Altafaj Spain 21 856 561 533 277 111 43 1.4k
Kenji Amano Japan 19 551 0.6× 328 0.6× 360 0.7× 276 1.0× 23 0.2× 36 1.1k
Shyue‐Fang Hsu United States 11 585 0.7× 460 0.8× 163 0.3× 358 1.3× 88 0.8× 12 1.3k
Tatyana Adayev United States 18 518 0.6× 336 0.6× 444 0.8× 177 0.6× 13 0.1× 30 1.1k
Bárbara Hämmerle Spain 15 485 0.6× 371 0.7× 345 0.6× 151 0.5× 15 0.1× 20 961
Matthew D. Wortman United States 19 833 1.0× 178 0.3× 160 0.3× 121 0.4× 22 0.2× 28 1.6k
Attila Szebeni United States 20 1.3k 1.6× 70 0.1× 199 0.4× 233 0.8× 54 0.5× 24 2.0k
Chaochao Cai United States 9 906 1.1× 168 0.3× 274 0.5× 53 0.2× 36 0.3× 11 1.5k
Lazar Z. Krsmanović United States 29 881 1.0× 170 0.3× 393 0.7× 479 1.7× 53 0.5× 50 2.3k
Katrine West United Kingdom 13 329 0.4× 261 0.5× 122 0.2× 422 1.5× 24 0.2× 18 1.3k
Jan N. Hansen Germany 20 480 0.6× 150 0.3× 229 0.4× 254 0.9× 12 0.1× 38 1.2k

Countries citing papers authored by Xavier Altafaj

Since Specialization
Citations

This map shows the geographic impact of Xavier Altafaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Altafaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Altafaj more than expected).

Fields of papers citing papers by Xavier Altafaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Altafaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Altafaj. The network helps show where Xavier Altafaj may publish in the future.

Co-authorship network of co-authors of Xavier Altafaj

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Altafaj. A scholar is included among the top collaborators of Xavier Altafaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Altafaj. Xavier Altafaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olivella, Mireia, et al.. (2023). Evidence for effect of l-serine, a novel therapy for GRIN2B-related neurodevelopmental disorder. Molecular Genetics and Metabolism. 138(3). 107523–107523. 10 indexed citations
2.
Wu, Vincen, Emrys A. Jones, James S. McKenzie, et al.. (2022). High Resolution Ambient MS Imaging of Biological Samples by Desorption Electro-Flow Focussing Ionization. Analytical Chemistry. 94(28). 10035–10044. 26 indexed citations
3.
Soto, David, et al.. (2022). Identification of homologous GluN subunits variants accelerates GRIN variants stratification. Frontiers in Cellular Neuroscience. 16. 998719–998719. 1 indexed citations
4.
Callado, Luís F., Ester Aso, Kristoffer Sahlholm, et al.. (2020). Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia. Neuropsychopharmacology. 46(3). 665–672. 30 indexed citations
5.
Kurbatskaya, Ksenia, Aminul I. Ahmed, Paul Grundy, et al.. (2019). A primate-specific short GluN2A-NMDA receptor isoform is expressed in the human brain. Molecular Brain. 12(1). 64–64. 17 indexed citations
6.
Grau, C. J. Alejos, et al.. (2018). Phosphoproteomic Alterations of Ionotropic Glutamate Receptors in the Hippocampus of the Ts65Dn Mouse Model of Down Syndrome. Frontiers in Molecular Neuroscience. 11. 226–226. 5 indexed citations
7.
Fernández‐Dueñas, Víctor, et al.. (2017). Adenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease. Frontiers in Neuroscience. 11. 652–652. 10 indexed citations
8.
Sindreu, Carlos, Àlex Bayés, Xavier Altafaj, & Jeús Pérez‐Clausell. (2014). Zinc transporter-1 concentrates at the postsynaptic density of hippocampal synapses. Molecular Brain. 7(1). 16–16. 29 indexed citations
9.
Fillat, Cristina, Xavier Bofill‐De Ros, Mònica Santos, et al.. (2014). Identificación de genes clave implicados en el síndrome de Down mediante terapia génica. Scopus (Elsevier). 18(2). 21–28. 1 indexed citations
10.
Fillat, Cristina & Xavier Altafaj. (2012). Gene therapy for Down syndrome. Progress in brain research. 197. 237–247. 8 indexed citations
11.
Altafaj, Xavier, et al.. (2012). Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome. Neurobiology of Disease. 52. 117–127. 56 indexed citations
12.
Chouabe, Christophe, et al.. (2011). Caveolin-3 is a direct molecular partner of the Cav1.1 subunit of the skeletal muscle L-type calcium channel. The International Journal of Biochemistry & Cell Biology. 43(5). 713–720. 13 indexed citations
13.
Fillat, Cristina, Mara Dierssen, María Martínez de Lagrán, & Xavier Altafaj. (2010). Insights from Mouse Models to Understand Neurodegeneration in Down Syndrome. CNS & Neurological Disorders - Drug Targets. 9(4). 429–438. 11 indexed citations
14.
Sahún, Ignasi, Xavier Altafaj, Núria Andreu, et al.. (2008). Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down Syndrome. The American Journal of Human Genetics. 83(4). 479–488. 54 indexed citations
15.
Altafaj, Xavier, Miriam Fernández, Marie‐Claude Potier, et al.. (2008). Increased NR2A expression and prolonged decay of NMDA-induced calcium transient in cerebellum of TgDyrk1A mice, a mouse model of Down syndrome. Neurobiology of Disease. 32(3). 377–384. 27 indexed citations
16.
Altafaj, Xavier, et al.. (2006). Oocyte Expression With Injection of Purified T7 RNA Polymerase. Methods in molecular biology. 322. 55–67. 8 indexed citations
17.
Altafaj, Xavier, Weijun Cheng, É. Estève, et al.. (2005). Maurocalcine and Domain A of the II-III Loop of the Dihydropyridine Receptor Cav 1.1 Subunit Share Common Binding Sites on the Skeletal Ryanodine Receptor. Journal of Biological Chemistry. 280(6). 4013–4016. 36 indexed citations
18.
Lagrán, María Martínez de, Xavier Altafaj, Xavier Gallego, et al.. (2003). Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction. Neurobiology of Disease. 15(1). 132–142. 64 indexed citations
19.
Dierssen, Mara, Eulàlia Martı́, Vassiliki Fotaki, et al.. (2001). Functional genomics of Down syndrome: a multidisciplinary approach. PubMed. 131–148. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Amano Breakdown of academic impact, for papers by Shyue‐Fang Hsu Breakdown of academic impact, for papers by Tatyana Adayev Breakdown of academic impact, for papers by Bárbara Hämmerle Breakdown of academic impact, for papers by Matthew D. Wortman Breakdown of academic impact, for papers by Attila Szebeni Breakdown of academic impact, for papers by Chaochao Cai Breakdown of academic impact, for papers by Lazar Z. Krsmanović Breakdown of academic impact, for papers by Katrine West Breakdown of academic impact, for papers by Jan N. Hansen
Rankless by CCL
2026